Structural Targeting of TREM2 in Alzheimer's Disease
Thomas Brett, Ph.D.
St. Louis , MO - United States
2025
Defining Short RNA Therapeutics that Reverse TDP-43 Proteinopathy
James Shorter, Ph.D.
Philadelphia, PA - United States
2025
Moving Beyond Amyloid and Tau to Capture the Biological Heterogeneity of Alzheimer's Disease
Tracy Young-Pearse, Ph.D.
Cambridge, MA - United States
2025
Aging and Dementia Research and Training (ADRET) Program in Uganda
Francis Bajunirwe, Ph.D.
Mbarara, Uganda
2024
Laura Baker
Winston-Salem, NC - United States
2024
Apolipoprotein E receptors as drug targets in Alzheimer's disease
Abdel Ali Belaidi, Ph.D.
Parkville, Australia
2024
Mapping the X Chromosome Multi-Ome in Alzheimer's and Parkinson's Disease
Michaël Belloy, Ph.D.
St. Louis, MO - United States
2024
Probing Vulnerability in Circuits for Social Behavior in FTD
Kristen Berendzen, Ph.D.
San Francisco, CA - United States
2024
Identifying mechanisms of an African-specific locus protective for AD
Luciana Bertholim Nasciben, Ph.D.
Miami, FL - United States
2024
Impaired Neuronal Cytoarchitecture in AD/ADRD
Merci Best, Ph.D.
Ann Arbor, MI - United States
2024
Myelin Loss and Cognitive Impairment Following SARS-CoV-2 Infection
Narlon Cassio Boa Sorte Silva, Ph.D.
Vancouver, Canada
2024
Targeting EV-Mediated Tau Propagation via P2X Purinoreceptor 7
Victor Bodart-Santos, Ph.D.
Jacksonville, FL - United States
2024
Relationship Between Sleep, Tau, and Race in Preclinical Alzheimer disease
Anthony Briggs, Ph.D.
New York, NY - United States
2024
Role of the transcription factor PU.1 in Alzheimer's Disease
Simone Brioschi, Ph.D.
St. Louis, MO - United States
2024
Neuroprotective Effects of "Hypothermia in a Syringe"
Sonja Broeer, D.V.M., Ph.D.
Berlin, Germany
2024
Investigating the Neurophysiologic Impact of Amyloid Removal Therapy in AD
Stephanie Buss, M.D.
Boston, MA - United States
2024
Fostering Equitable Dementia Care for Hispanic/Latino Communities
Sara Bybee, Ph.D.
Salt Lake City, UT - United States
2024
Restoring Depalmitoylation in Alzheimer’s Disease Cellular and Mouse Models
Skarleth Cardenas Romero, Ph.D.
Brookline, MA - United States
2024
Stratifying ARIA risk with cerebral amyloid angiopathy biomarkers
Andreas Charidimou, M.D., Ph.D.
Boston, MA - United States
2024
Social isolation and dementia risk: cross-national and temporal comparison
Ruijia Chen, ScD
Lexington, MA - United States
2024
Proteomics Profiling of Microglia for Cognitive Resilience in AD
Yu Chen, Ph.D.
Ann Arbor, MI - United States
2024
Glymphatic Activity and Preclinical Alzheimer's Disease Pathogenesis
Gawon Cho, Ph.D.
New Haven, CT - United States
2024
Stephen Choi, Ph.D.
Toronto, Canada
2024
Endosomal Control of Protein Synthesis in Alzheimer’s Disease
Jean-Michel Cioni, Ph.D.
Milan, Italy
2024
Developing CRISPR genome therapy for Alzheimer's disease
Claire Clelland, M.D, Ph.D.
San Francisco, CA - United States
2024
Identification of Functional Cis-regulatory Elements of APP
Jesse Cochran, Ph.D.
Huntsville, AL - United States
2024
Decoding the signaling contexts underlying human glial cell-state landscape
Natacha Comandante-Lou, Ph.D.
New York, NY - United States
2024
Therapeutic potential of nicotinic acid in PS19 tauopathy mice
Israel Coronel-Morales, Ph.D.
Indianapolis, IN - United States
2024
Epidemiology and deep phenotyping of Argentinian patients with tauopathies
Blas Couto, Ph.D.
Buenos Aires, Argentina
2024
Resilience in Andean American Indigenous with Alzheimer's disease
Nilton Custodio, M.D., Ph.D.
Lima, Peru
2024
Defining the Role of Clonal Hematopoiesis in Alzheimer’s Disease
Frederik Damm, M.D.
Berlin, Germany
2024
Preclinical evaluation of potential cholinergic PET imaging tracers
Taher Darreh-Shori, Ph.D.
Stockholm, Sweden
2024
Genetic and environmental contributions to longitudinal tau trajectories
Anouk den Baraber, Ph.D.
Amsterdam, Netherlands
2024
Deciphering Early AD Progression via Olfactory System and AQP4 Dynamics
Michele Dibattista, Ph.D.
Bari, Italy
2024
Racial Residential Segregation, Neighborhood Deprivation and ADRD Risk
Paola Filigrana, Ph.D.
Bronx, NY - United States
2024
The Amygdala as Gateway and Gatekeeper to Lewy Body Co-pathology
David Fischer, M.D.
San Francisco, CA - United States
2024
Proteomic signatures of cognitive resilience in excitatory cortical neurons
Lauren Fish, Ph.D.
Ann Arbor, MI - United States
2024
Understanding Affective Symptoms in Dementia by Peripheral Immune Changes
Daniel Fisher, M.D., Ph.D.
Seattle, WA - United States
2024
Investigating aberrant cellular mechanics as early event of tau pathology
Martha Foiani, Ph.D.
London, United Kingdom
2024
Life course BP trajectories and time to dementia in Black aging persons
Sarah Forrester, Ph.D.
Worcester, MA - United States
2024
Understanding the Negative Impact of APOE4 on Neural Responses to Estrogens
Karyn Frick, Ph.D.
Milwaukee, WI - United States
2024
The role of the CXCL9-11/CXCR3 cascade in frontotemporal dementia pathology
Nazaret Gamez, Ph.D.
Houston, TX - United States
2024
Characterizing the Cognitive and Neuroimaging Profile of LATE-NC
Leslie Gaynor, Ph.D.
Nashville, TN - United States
2024
Lifecourse Vascular Contributions to Dementia Among Diverse Older Adults
Kristen George, Ph.D.
Davis, CA - United States
2024
The role of myelin in Alzheimer's Disease
Marios Georgiadis, Ph.D.
Stanford, CA - United States
2024
Contribution of Sleep Loss and Sex in AD-Related Pathogenesis
Nicole Gervais, Ph.D.
Groningen, Netherlands
2024
Reframing Alzheimer's Disease as a Developmental Disorder
Brian Gordon, Ph.D.
St. Louis, MS - United States
2024
METHODEM: Methodological consensus for complex interventions in dementia
Maud Graff, Ph.D.
Nijmegen, Netherlands
2024
The Influence of Neighborhood Context on Cognition and Research Recruitment
Jeremy Galen Grant, Ph.D.
Columbus, OH - United States
2024
Evidence-Based Speech-Language Intervention in Latinxs of Mexican Origin
Stephanie Grasso, Ph.D.
Austin, TX - United States
2024
In Vivo Roles of Rejuvenating Blood-Borne Factors in Amyloid-Beta Metabolism
Alejandro Borja Grau Perales, Ph.D.
New York, NY - United States
2024
Short Tandem Repeats as a Novel Genetic Driver of Alzheimer's Disease
Michael Guo, M.D., Ph.D.
Philadelphia, PA - United States
2024
Targeting Polyglutamylated Tubulin as an Early Treatment Strategy for AD
Torben Hausrat, Ph.D.
Hamburg, Germany
2024
Developing an At-Home VR Activity Training Program for People with AD/ADRD
Jung Hee-Tae, Ph.D.
Indianapolis, IN - United States
2024
The gut-brain-axis in Alzheimer's disease-related metabolic impairment
Abbi Hernandez, Ph.D.
Birmingham, AL - United States
2024
Metabolomics, socioeconomic conditions, and cognitive decline
César Higgins Tejera, Ph.D.
Baltimore, MD - United States
2024
Deep tissue multiphoton imaging of the hippocampus in Alzheimer’s disease
Steven Hou, Ph.D.
Boston, MA - United States
2024
Ventral Hippocampal Circuitry Underlying Neuropsychiatric Symptoms in AD
Holly Hunsberger, Ph.D.
North Chicago, IL - United States
2024
Oligodendrocyte dysfunction in AD revealed by nascent proteomics.
Tal Iram, Ph.D.
Stanford, CA - United States
2024
Microglia-Mediated Mitochondrial Calcium Signaling in Alzheimer's Disease
Pooja Jadiya, Ph.D.
Winston-Salem, NC - United States
2024
Replacement of Peripheral APOE4 with APOE2: Effects on AD Pathology
Lance Johnson, Ph.D.
Lexington, KY - United States
2024
Develop Framework for Management and Aggregation of Datasets
Astha Kapoor
Bangalore, India
2024
Tau and cortical functional network dynamics in Alzheimer's disease
Yuta Katsumi, Ph.D.
Boston, MA - United States
2024
Identifying the Mechanisms that Underlie Tau Aggregation and Neurotoxicity
Sarah Kaufman, M.D., Ph.D.
San Francisco, CA - United States
2024
Inspecting the Heterogeneity Linked to Axonal TDP-43 Pathology in Dementias
Bilal Khalil, Ph.D.
Leuven, Belgium
2024
Brain metabolism and genetic risk factors: An imaging study in AD Mice
Chalermchai Khemtong, Ph.D.
Gainsville, FL - United States
2024
Culturally-tailored Stress Reduction Program for Korean ADRD Caregivers
Hyejin Kim, Ph.D., RN
Chicago, IL - United States
2024
PET imaging of neuroinflammation in dementia with Lewy bodies
Min-Jeong Kim, M.D., Ph.D.
Stony Brook, NY - United States
2024
Increasing Neuroimaging Access of Dementia Through Low-Field Portable MRI
William Taylor Kimberly, M.D., Ph.D.
Boston, MA - United States
2024
Effect of Passive Amylin Immunotherapy on Amylin and Beta-Amyloid Plaque Burden in AD
Deepak Kotiya, Ph.D.
Lexington, KY - United States
2024
Mechanisms of White Matter Injury in Alzheimer's Disease and Mixed Dementia
Andrew Kraft, M.D., Ph.D.
Cambridge, MA - United States
2024
Lifecourse Socioeconomic Factors and Plasma AD Biomarkers
Anna Kucharska-Newton, Ph.D.
Chapel Hill, NC - United States
2024
Dissecting the Role of Astrocyte Network in AD-Associated Sleep Disturbance
Baoling Lai, Ph.D.
New York, NY - United States
2024
Minnesota American Indian Dementia Surveillance System
Genelle Lamont, Ph.D.
Duluth, MN - United States
2024
A novel bispecific antibody targeting amyloid beta
Jose Henrique Ledo, Ph.D.
Charleston, SC - United States
2024
Going Home: Reminiscence Intervention for Asian Immigrants with Dementia
Yura Lee, Ph.D.
Milwaukee, WI - United States
2024
Unveiling the Neurovascular Responses to Amyloid-Beta Antibodies
Wonjae Lee, Ph.D.
Durham, NC - United States
2024
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
Knoo Lee, Ph.D.
Columbia, MO - United States
2024
Genomic Link between Vascular Risk Factors and AD in Diverse Populations
Annie Lee, Ph.D.
New York, NY - United States
2024
Socioemotional mechanisms underlying social vulnerability in dementia
Jayden Lee, Ph.D.
Nashville, TN - United States
2024
Deciphering Alzheimer's Astro-Neuron Energy Link at Micro-Niche resolution
Julio Leon Incio, Ph.D.
San Francisco, CA - United States
2024
Cardiometabolic Risk Factors and Lewy Body Disease Symptom Progression
Shellie-Anne Levy, Ph.D.
Gainesville, FL - United States
2024
Engineering importins to counter TDP-43 pathology in Alzheimer's Disease
Miriam Linsenmeier, Ph.D.
Philadelphia, PA - United States
2024
Biomarkers linking SARS-CoV2 Infection to the Risk of ADRD
Richard Lipton
Bronx, NY - United States
2024
Structure and Toxicity of a Specific Tau Oligomer Related to Dementia
Peng Liu, Ph.D.
Minneapolis, MN - United States
2024
Biological Aging Underlies Neurodegeneration Across the Adult Lifespan
Dan Liu, Ph.D.
Bonn, Germany
2024
Targeting late-life depression to mitigate Alzheimer's dementia
Victor Luna, Ph.D.
Philadelphia, PA - United States
2024
Alternative APOE transcripts and Alzheimer's disease
Liang Ma, Ph.D.
San Antonio, TX - United States
2024
Early Dementia Detection in Vietnamese Speaking Populations in Primary Care
Kris Pui Kwan Ma, Ph.D.
Seattle, WA - United States
2024
Impaired Microglial Modulation of Neuronal Function in Alzheimer’s Disease
Keran Ma, Ph.D.
Houston, TX - United States
2024
Home-Based tDCS for Affective Symptoms
Thiago Macedo e Cordeiro, M.D.
San Antonio, TX - United States
2024
Role of 3D chromatin in Alternative Isoform Choice in Health and Dementia
Valeriya Malysheva, Ph.D.
Wilrijk, Belgium
2024
APOE Modifiers of Human Microglia Biology in Alzheimer’s disease
Renzo Mancuso, Ph.D.
Ghent, Belgium
2024
S14 Sphingomyelin – The Link Between Obesity and Alzheimer’s Disease
Roisin McManus, Ph.D.
Bonn, Germany
2024
The Impact of Metabolic Signatures of the MIND Diet on Brain Aging
Debora Melo van Lent, Ph.D.
San Antonio, TX - United States
2024
Impact of Sex-Specific Dopamine Alteration in Midlife on AD Pathology
Carole Morel, Ph.D.
New York, NY - United States
2024
Olfactory Training in Mild Cognitive Impairment
Jeffrey Motter, Ph.D.
New York, NY - United States
2024
Optimising interpreter mediated dementia diagnostic assessments
Naaheed Mukadam, Ph.D.
London, United Kingdom
2024
Effectiveness of a dementia anti-stigma intervention in rural Kenya
Christine Wayua Musyimi, Ph.D.
Nairobi, Kenya
2024
Uncovering the Molecular Pathogenesis of Semantic Dementia
Malik Nassan, M.D.
Chicago, IL - United States
2024
Dissecting Commissures' role in Neurodegeneration using Genetic Techniques
Carolina Ochoa-Rosales, Ph.D.
Santiago, Chile
2024
Studies of MOAG-4/SERF-2 as a link between obesity and Alzheimer's disease
Eyleen O'Rourke, Ph.D.
Charlottesville, VA - United States
2024
Dynamic interplay of vascular injury and inflammation on AD progression
Julie Ottoy, Ph.D.
Toronto, Canada
2024
Characterizing Doxorubicin-Induced Cognitive Impairment in APOE Mouse Model
Harshul Pandit, Ph.D.
Washington, DC - United States
2024
Blood pTau validation of Alzheimer disease in high-risk populations
Song-Yi Park, Ph.D.
Honolulu, HI - United States
2024
Sex-specific vulnerability mediated by Parvalbumin neurons in Alzheimer's disease
Arnaldo Parra-Damas, Ph.D.
Bellaterra, Spain
2024
Development and testing of QUALity of Interactions Inventory (QUALII)
Anju Paudel, Ph.D., R.N.
State College , PA - United States
2024
Dichotomy of Microglial C1q in the progression of Alzheimer’s Disease
Tiffany Petrisko, Ph.D.
Irvine, CA - United States
2024
Lithiated gold nanoparticles as promising therapy for Alzheimer's disease
Roberto Piacentini, Ph.D.
Milan, Italy
2024
Sarah Pickles, Ph.D.
Jacksonville, FL - United States
2024
Dissemination and Implementation of the Care Ecosystem Across Diverse Health Systems
Katherine Possin
San Francisco, CA - United States
2024
Harmonization of Tau PET Tracers to a Common Scale Using Head-to-Head Data
Guilherme Povala, Ph.D.
Pittsburgh, PA - United States
2024
Genetic Risk of Mixed Pathology in Alzheimer’s Disease in Multi-Ethnicities
Jung-Min Pyun, Ph.D.
Seoul, Korea (Republic of)
2024
Exploring the role of SEL1L-HRD1 ERAD in Alzheimer's Disease
Ling Qi, Ph.D.
Charlottesville, VA - United States
2024
Bi-phasic microtubule-based mechanisms and therapies for tauopathies
Liang Qiang, M.D., Ph.D.
Philadelphia, PA - United States
2024
Cis proline kinase in the development and therapy of Alzheimer's disease
Chenxi Qiu, Ph.D.
Boston, MA - United States
2024
Advance care planning and end of life in cognitively impaired older adults
Zahra Rahemi, Ph.D.
Clemson, SC - United States
2024
Quantifying Dose-Response of Music for Neuropsychiatric Symptoms of ADRD
Kendra Ray, Ph.D.
New York , NY - United States
2024
Assistive Robots and Intelligent devices for Alzheimer’s disease
Carmine Tommaso Recchiuto, Ph.D.
Genova, Italy
2024
Biological validation of MBI as part of the ADRD spectrum
Natalia Rocha, Ph.D.
Houston, TX - United States
2024
Developing a mouse model of auditory dysfunction in Alzheimer’s Disease
Chris Rodgers, Ph.D.
Atlanta, GA - United States
2024
Role of cholesterol metabolism to microglia reactivity and tau spreading
Matheus Rodrigues, PhD
Pittsburgh, PA - United States
2024
LACTB as a novel mitochondrial AD risk gene in microglial cells
Carmen Romero-Molina, Ph.D.
New York, NY - United States
2024
Australian Dementia Network Registry: RWD Therapy Surveillance Program
Christopher Rowe, M.D.
Victoria, Australia
2024
How Do Meningeal Lymphatics Affect Cerebral Amyloid Angiopathy?
Fareeha Saadi, Ph.D.
St Louis, MO - United States
2024
Measuring What Matters: Incorporating Person-Centered Outcomes in Adult Day
Tina Sadarangani, Ph.D., R.N.
New York, NY - United States
2024
Multimodal AI based Predictor of Alzheimer’s Disease (MAP-AD)
Apoorva Safai, Ph.D.
Madison, WI - United States
2024
Impact of arterial stiffening on cerebrovascular and cognitive function
Monica Santisteban, Ph.D.
Nashville, TN - United States
2024
Supplement to Novel mouse models to study the biology of APOE variant risk
Michael Sasner, Ph.D.
Bar Harbor, ME - United States
2024
Towards an Equitable Alternative for Early Alzheimer’s Disease Screening
Sydney Schaefer, Ph.D.
Tempe, AZ - United States
2024
Glial Reactivity Marker Predictive Value on Neuropsychiatric Symptoms in AD
Cristiano Schaffer Aguzzoli, M.D.
Porto Alegre, PA - Brazil
2024
Uncovering Mechanisms APOE Genotype-Mediated Alzheimer’s Disease Risk
Jessica Schwarz, Ph.D.
New York, NY - United States
2024
Measuring and Improving the Quality of Community-Based Dementia Care
Dallas Seitz, M.D., Ph.D.
Calgary, Canada
2024
Validation of MAO-B as a PET Biomarker of Reactive Astrogliosis in ADRD
Alberto Serrano-Pozo, M.D., Ph.D.
Charlestown, MA - United States
2024
Understanding how parental history of dementia influences offspring AD risk
Mabel Seto, Ph.D.
Boston, MA - United States
2024
Pharmaco-Omics Approach Linking Hormone Therapy And Alzheimer's Disease
Amanda Seyerle, Ph.D.
Chapel Hill, NC - United States
2024
Innovating the Evaluation of Rejection of Care in Hospital Dementia Care
Clarissa Shaw, Ph.D., RN
Iowa City, IA - United States
2024
AD Progression Biomarkers in Individuals with Subjective Cognitive Decline
Zhaoyue Shi, Ph.D.
Urbana, IL - United States
2024
DevoAPOE: Developmental APOE Controls Adult Microglia Function
Amanda Sierra, Ph.D.
Leioa, Spain
2024
Astrocyte Biomarkers in Alzheimer's Disease: Bridging Plasma and Brain
Andreia Silva da Rocha, Ph.D.
Pittsburgh, PA - United States
2024
Oral Health: A Window to Improve Systemic Immune Response in AD Patients
Marta Sochocka, Ph.D.
Wroclaw, Poland
2024
laili Soleimani
New York, NY - United States
2024
Structural and mechanistic understanding of gamma-secretase modulation
Mohamed Belal Hamed Soliman, Ph.D
Gent, Belgium
2024
Social Determinants of Health and Neurodegeneration: The Strong Heart Study
Amiri Solmaz, M.D., Ph.D.
Pullman, WA - United States
2024
The impacts of postoperative delirium on AD progression
Chengcheng Song, Ph.D.
Durham, NC - United States
2024
Dosage effect of APP to induced neuronal degeneration in Down syndrome
Lucas Sosa, M.D., Ph.D.
Córdoba, Argentina
2024
The Role of APOE4 in Synaptic Mitochondrial Dysfunction
Kelly Stauch, Ph.D.
Omaha, NE - United States
2024
Identification of Modifiers of APOEe4 Toxicity
Beth Stevens, Ph.D.
Boston, MA - United States
2024
Building Capacity in Neuropathology in a Low- and Middle-Income Country
Claudia Suemoto, M.D., Ph.D.
Sao Paulo, Brazil
2024
Unraveling the Therapeutic Potential of SPPL2b in Alzheimer's Disease
Simone Tambaro, Ph.D.
Stockholm, Sweden
2024
Deciphering TDP-43 molecular signatures in LATE, AD and related dementias
Sandra O. Tomé, Ph.D.
Leuven, Belgium
2024
Novel AD Plasma Biomarker Machine Learning Analysis & Molecular Validation
Amy Tsurumi, Ph.D.
Boston, MA - United States
2024
Functional Connectivity-Guided rTMS for Personalized Treatment of Apathy
Shankar Tumati, Ph.D.
Toronto, Canada
2024
In Vivo Quantification of Entorhinal Cortex Layer II Along the AD Continuum
Yuto Uchida, M.D., Ph.D.
Baltimore, MD - United States
2024
The ABOARD Cohort: Collecting Real-World Data to Advance Alzheimer’s Research in the Netherlands
Wiesje van der Flier, Ph.D.
Amsterdam, Netherlands
2024
Bioactive Lipids, Cognitive Phenotypes, and Cognitive Function
Chirag Vyas, M.D.
Boston, MA - United States
2024
Cerebral capillary hyperemia in the transition of aging to late-onset AD
Jiandi Wan, Ph.D.
Davis, CA - United States
2024
Elucidating the role of vascular dysfunction in LATE, LATE-AD, and FTLD-TDP
Shih-Hsiu Wang, M.D., Ph.D.
Durham, NC - United States
2024
Understanding the Role of the Complement Pathway in Alzheimer's Disease
Naoto Watamura, Ph.D.
London, United Kingdom
2024
Emulating Early Physical Activity and Multidomain Interventions on ADRD
Jingkai Wei, Ph.D.
Columbia, SC - United States
2024
Spatial transcriptomic profiling of neuron-engulfing microglia
Lindsay Welikovitch, Ph.D.
Boston, MA - United States
2024
Jeff Williamson
Winston-Salem, NC - United States
2024
Comprehensive Gene-Environment Interactions on Alzheimer’s Disease
Xian Wu, Ph.D.
Lexington, KY - United States
2024
Exploring the Physiological and Pathological Functions of BRI2 in Neurons
Metin Yesiltepe, M.D.
Newark, NJ - United States
2024
Neuroimaging Genetics of the Glymphatic System in Alzheimer`s Disease
Kyan Younes, M.D.
Palo Alto, CA - United States
2024
Nam Younji, Ph.D.
Miami, FL - United States
2024
Impact of systemic interferon responses in Alzheimer's disease
I-Chen Yu, Ph.D.
Bloomington, IN - United States
2024
Care recipients' health trajectories and unpaid caregiving costs
Emma Zang, Ph.D.
New Haven, CT - United States
2024
Development of chemical exchange saturation transfer MRI for dementia with Lewy bodies
Phillip Zhe Sun, Ph.D.
Altanta, GA - United States
2024
Targeting mitochondrial metabolism in AD
Xuewei Zhu, Ph.D.
Winston-Salem, NC - United States
2024
Uncovering miRNA-mediated Adipose-Brain Crosstalk in Alzheimer’s Disease
Marcelo A. Mori, Ph.D.
Campinas, Brazil
2023
Association Between Longitudinal Changes in Plasma GFAP and AD Progression
Sarah Abbas, Ph.D.
Pittsburgh, PA - United States
2023
Vascular cognitive impairment in diabetes: mechanisms and intervention
Kareem Abdelsaid, Ph.D.
Charleston, SC - United States
2023
Identifying ethnic disparities in AD risk and blood biomarkers in Israel
Maison Abu Raya, M.D.
Haifa, Israel
2023
Inclusive ADRD Clinical Trials: Screening, Enrolling Latino Participants
G. Adriana Perez, Ph.D.
Philadelphia, PA - United States
2023
Identification of retromer modifiers by arrayed genome-wide perturbation
Adriano Aguzzi, M.D.
Zurich, Switzerland
2023
Pyroptosis-induced gut-brain disruption after Stroke in Alzheimer’s disease
Nadine Ahmed Kerr, Ph.D.
Miami, FL - United States
2023
Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models
Moustafa Algamal, Ph.D.
Boston, MA - United States
2023
Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes
Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023
Identifying Astrocyte-Mediated Vasomotion Underlying AD Pathogenesis
Xiaoqing Alice Zhou, Ph.D.
Boston, MA - United States
2023
Uncovering the Role of SORL1 as a Key Regulator of AD Endosomal Pathology
Brooke Alisen DeRosa, Ph.D.
Miami, FL - United States
2023
Influence of the Microenvironment on the Turnover of Fluid Biomarkers
Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023
Dementia training for primary health care workers in Ethiopia
Mohammed Anbessie, M.D.
Addis Ababa, Ethiopia
2023
Interrogating Metabolic Dysregulation in Neurodegeneration Using Organoids
Madeline Andrews, Ph.D.
Tempe, AZ - United States
2023
Kv7 K+ channels, BACE1, APP, and Alzheimer's disease-related epilepsy
Fabio Antonio Borges Vigil, Ph.D.
San Antonio, TX - United States
2023
Multi-Omics Characterization of a Diverse Population in the South of Brazil
Marco Antônio De Bastiani, Ph.D.
PORTO ALEGRE, Brazil
2023
Liana Apostolova, M.D.
Indianapolis, IN - United States
2023
Targeted Network Attack in Assessing Brain Resilience
Georgette Argiris, Ph.D.
New York, NY - United States
2023
The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction
Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023
Assessing Meaningful Engagement in Advanced Dementia (MEAD)
Arlene Astell, Ph.D.
Toronto, Canada
2023
A CRISPR-Based Therapeutic for Alzheimer's disease
Brent Aulston, Ph.D.
La Jolla, CA - United States
2023
A Clinical Quality Registry for Dementia in Ethiopia (CQRD Ethiopia)
Biniyam Ayele, M.D.
Addis Ababa, Ethiopia
2023
Hypothalamic Nuclei and the Spatiotemporal Evolution of Alzheimer’s disease
Marion Baillet, Ph.D.
Liege, Belgium
2023
“Land of the Young”: Changing dementia narratives in Hollywood
Zach Bandler
Dublin, Ireland
2023
Circuit Targets to Rescue Memory Functions in Alzheimer’s Disease
Jayeeta Basu, Ph.D.
New York, NY - United States
2023
Underlying effects of ApoE variants on brain pericytes in CAA and AD
Praveen Bathini, Ph.D.
Boston, MA - United States
2023
AD Nanomedicines Targeting Vasculature Disfunction and Neuroinflammation
Giuseppe Battaglia, Ph.D.
Barcelona, Spain
2023
A Deep Learning Tool to Generalize Tau PET to Predict AD progression
Guilherme Bauer Negrini, Ph.D.
Pittsburgh, PA - United States
2023
Determining the Impact of Tau Aggregates on Neuron Loss with 2P Imaging
Rachel Bennett, Ph.D.
Boston, MA - United States
2023
Mechanisms of Complement Mediated Synaptic Removal Following Tauopathy
Matthew Benskey, Ph.D.
Grand Rapids, MI - United States
2023
Arts workshops for older Latino adults with MCI at museums
Veronica Birgit Rojas Carstensen, MFA
San Francisco, CA - United States
2023
Kaj Blennow
Gothenburg, Sweden
2023
Uncovering Mechanisms of Neuronal Hyperexcitability in Tauopathies
Steven Boggess, Ph.D.
San Francisco, CA - United States
2023
Blood Redox Biomarker for Dementia
Gregory Brewer, Ph.D.
Irvine, CA - United States
2023
Jake Broder
Princeton, NJ - United States
2023
Individualized Prediction of Tau Propagation Using Diffusion Tensor Imaging
Christopher Brown, Ph.D.
Philadelphia, PA - United States
2023
The Role of Pregnancy History in Women at Risk for Alzheimer’s disease
Anna Brugulat-Serrat, Ph.D.
Barcelona, Spain
2023
Luc Buée, Ph.D.
Lille, France
2023
Patterns & Preferences of Home-Based Service Use for Persons with Dementia
Dr. Julia Burgdorf, Ph.D.
New York, NY - United States
2023
Uncovering Mechanisms of Axonal Pathology in Alzheimer's disease
Yifei Cai, Ph.D.
New Haven, CT - United States
2023
Continued Development of the Next Generation Environmental Assessment Tool
Margaret P Calkins. Ph.D.
Cleveland Heights, OH - United States
2023
Resolving Cellular Resilience and Resistance to Alzheimer’s Disease
Isabel Castanho, Ph.D.
Boston, MA - United States
2023
Combined Lecanemab Immunotherapy and BDNF Gene Therapy for AD
Michael J. Castle, Ph.D.
San Diego , CA - United States
2023
Functional Analysis of the PSEN1 G206A Variant in Hispanics with Alzheimer's Disease
Katrina Celis, M.D.
Miami, FL - United States
2023
Therapeutic Potential of Lysine Crotonylation in Alzheimer's Disease
Snehajyoti Chatterjee, Ph.D.
Iowa City, IA - United States
2023
Mechanisms of Gamma-Secretase Modulators, Towards Rational Drug Design
Lucía Chávez-Gutiérrez, Ph.D.
Gent, Belgium
2023
What's your passion? Reliving Memories Short Documentary
Carlos Chechetti
Sao Paulo, Brazil
2023
Immune cells regulate tau pathology and tau-mediated neurodegeneration
Xiaoying Chen, Ph.D.
Saint Louis, MO - United States
2023
MEG Predictors of Social Learning in Early AD and Behavioral-Variant FTD
Yu Chen, M.D., Ph.D.
San Francisco, CA - United States
2023
Evaluation of Alzheimer's Endophenotype Networks Between Human and Mouse
Feixiong Cheng, Ph.D.
Cleveland, OH - United States
2023
The Impact of Social Determinants of Health on Brain Health in South Korea
Hanna Cho, Ph.D.
Seoul, United States
2023
Alzheimer’s Disease and Related Dementias in Gender Minority Adults
Ethan Collin Cicero, Ph.D.
Atlanta, GA - United States
2023
Can Subtyping of Alzheimer’s Heterogeneity Improve Clinical Trial Design?
Lyduine Collij, Ph.D.
Amsterdam, Netherlands
2023
Understanding the role of AD endocytic risk genes in disease pathogenesis.
Natalie Connor-Robson, Ph.D.
Cardiff, United Kingdom
2023
Promoting Wellbeing Through Music and Movement in Familial AD
Catherine Correa-Lopera
Medellin, Colombia
2023
Cognitive Functioning and Gender-Affirming Hormones in Transgender Adults
Anthony Correro, Ph.D.
Milwaukee, WI - United States
2023
Evaluating Memory as Part of Women's Routine Care
Stephanie Cosentino, Ph.D.
New York, NY - United States
2023
Medicare Beneficiary and Caregiver Outcomes After an MCI Diagnosis
Elyse Couch, Ph.D.
Providence, RI - United States
2023
Menopause, Hormone Therapy and Clinicopathology: An In-Vivo Perspective
Gillian Coughlan, Ph.D.
Boston, MA - United States
2023
Crossing international borders for dementia care: Migrating Indian families
Jayashree Dasgupta, Ph.D.
Dehli, India
2023
Cellular and molecular mechanisms mediating pT217-tau phosphorylation in AD
Dibyadeep Datta, Ph.D.
New Haven, CT - United States
2023
ApoE Lipid Transport by ABCA7 Genetic Variants
Jamaine Davis, Ph.D.
Nashville, TN - United States
2023
Digital Platform for Precision Brain Health in the Bogalusa Heart Study
Ileana De Anda-Duran, M.D., MPH
New Orleans, LA - United States
2023
Diet and brain health in Mexican adults
Vanessa De la Cruz, Ph.D.
Cuernavaca, Mexico
2023
A Novel Item-Level Category Fluency Scoring to Detect AD at the MCI Stage
Matteo De Marco, Ph.D.
Uxbridge, United Kingdom
2023
Studying the role of microglia-specific endolysosomal dysfunction in AD
Bart de Strooper, M.D., Ph.D.
Leuven, Belgium
2023
Sex difference in cognitive impairment in a novel humanized AD model
Ferenc Deak, Ph.D.
Augusta, GA - United States
2023
Synaptic Dysfunction in Alzheimer's disease.
Maria del Pilar Rivero Rios, Ph.D.
Ann Arbor, MI - United States
2023
High-spatial-resolution Sequencing to Study Alzheimer's Disease
Yanxiang Deng, Ph.D.
Philadelphia, PA - United States
2023
Linking Integrin Dysfunction with Tauopathy in a LOAD Model
Christine Dengler-Crish, Ph.D.
Rootstown, OH - United States
2023
Identifying the novel mechanism of LPS-DHA and therapeutic approach for ADD
Sugasini Dhavamani, Ph.D.
Chicago, IL - United States
2023
Neuroimage-Genetic Integration to Investigate Risk and Resilience in AD
Ibai Diez, Ph.D.
Boston, MA - United States
2023
Assistive Technology to Support People with MCI & Dementia in the Workplace
Emma Dixon, Ph.D.
Clemson, SC - United States
2023
The Role of CYLD and its Partners in Frontotemporal Dementia
Carol Dobson-Stone, Ph.D.
Sydney, Australia
2023
Unraveling the Cell-Type Specific Role of TMEM106B in Tauopathy
George Edwards III, Ph.D.
Houston, TX - United States
2023
Association of multidimensional poverty with Cognitive function in DRCongo
Emmanuel Epenge, M.S.
Kinshasa, Congo (Dem. Republic)
2023
Sleep and AD Risk Among Older African Americans
Darlingtina Esiaka, Ph.D.
Newark, NJ - United States
2023
Inclusive environments for PwD from rural areas of Chile and their families
Macarena Prince Espina
Santiago, Chile
2023
Decoding Epigenetic Scarring in Alzheimer’s disease
Huihui Fan, Ph.D.
Houston, TX - United States
2023
Reprogramming Endothelial Cells to Prevent and Treat Alzheimer Disease
Camilla Ferreira Wenceslau, Ph.D.
Columbia, SC - United States
2023
Cerebrovascular Pathology Across the Alzheimer's Ccontinuum in Down syndrome
Lisi Flores Aguilar, Ph.D.
Irvine, CA - United States
2023
Determining the Mechanisms of Anti-Beta-Amyloid Immunotherapy on ARIA
Kate Foley, Ph.D.
Indianapolis, IN - United States
2023
SUMO2 Protein Replacement Therapy to Counteract Tau Toxicity in AD
Paul E. Fraser, Ph.D.
Toronto, Canada
2023
Leveraging Longitudinal Cohort Data to Assess Sleep as a Risk Factor for AD
Kelsie Full, Ph.D.
Nashville, TN - United States
2023
Comprehensive Multi-Neuron Imaging of Neurodegeneration in C. elegans
Christopher Gabel, Ph.D.
Boston, MA - United States
2023
Sleep/circadian Regulation and Progression to Postoperative Dementia
Lei Gao, Ph.D.
Boston, MA - United States
2023
SHIP1 Agonism and Lipid Burden in Alzheimer's Disease
William Garrow Kerr, Ph.D.
Syracuse, NY - United States
2023
Data Integration Strategies to Study Gene Expression in Alzheimer's Disease
David Gate, Ph.D.
Chicago, IL - United States
2023
Entirely Human: performing the person in dementia
Dominic Gately
Bradford, United Kingdom
2023
Person-Centered Outcome Measures for AD Patient Emergency Care Experiences
Andrea Gilmore-Bykovskyi, Ph.D.
Madison, WI - United States
2023
Towards The Molecular Map of Blood Vessels in Health and Neurodegeneration
Ricardo Giordano, Ph.D.
São Paulo, Brazil
2023
Multimodal Models for Triage of Cognitive Decline and AD Pathology
Joseph Giorgio, Ph.D.
Berkeley, CA - United States
2023
Cognitive Reserve in Latin America: Evidence from Mexico and Brazil
Natlia Gomes Gonçalves, Ph.D.
Sao Paulo, Brazil
2023
Microbeam Radiation Therapy as a Novel Treatment for Alzheimer's Disease
Michael Grams, Ph.D.
Rochester, MN - United States
2023
Alcohol Use and APOE Genotype in Alzheimer's Disease Risk
Danielle Gulick, Ph.D.
Tampa, FL - United States
2023
Risk for Alzheimer’s disease in older adults with long-COVID
Edmarie Guzman-Velez, Ph.D.
Boston, MA - United States
2023
Hope - Ronald the rooster and other short stories in the days of Dementia
Mike Hanrahan
Navan, Iceland
2023
Oskar Hansson
Malmoe, Sweden
2023
Clinical Relevance of Novel Biomarkers for Tau and Alpha-Synuclein Pathology
Oskar Hansson, M.D.,Ph.D.
Lund, Sweden
2023
Elucidating the Proteinopathic Drivers of Network Dysfunction in AD
Samuel Harris, Ph.D.
London, United Kingdom
2023
Novel Immune Cell Bioindicators as Diagnostic and Therapeutic Targets
Daniel Hawiger M.D., Ph.D.
St. Louis, MO - United States
2023
Variation in Dementia Diagnosis Across Primary Care Physicians
Sidra Haye, Ph.D.
Los Angeles, CA - United States
2023
Cortico-Hippocampal Dysfunction in the Progression of Alzheimer's disease
Melissa Hernandez Frausto, Ph.D.
New York, NY - United States
2023
Role of Astrocytes in Microglia-Synapse Engulfment
Soyon Hong, Ph.D.
London, United Kingdom
2023
Understanding microglial lysosomal biology in Alzheimer's disease
Soyon Hong, Ph.D.
London, United Kingdom
2023
Nanoscale Mechanisms of NMDAR Dysfunction in AD
Martin Hruska, Ph.D.
Morgantown, WV - United States
2023
Tau as a Self-Antigen that Drives T Cell Immunity in Alzheimer's disease
Hao Hu, Ph.D.
Saint Louis, MO - United States
2023
Biased GPR3 Signaling Modulates Neuronal Function in AD mice and iNs
Yunhong Huang, Ph.D.
Pittsburgh, PA - United States
2023
Social Networks Over the Adult Life Course and Cognitive Eesilience
Phillip Hwang, Ph.D.
Boston, MA - United States
2023
Pathways Linking Neighborhood and Behavioral Factors to the Risk of ADRD
Jinshil Hyun, Ph.D.
Bronx, NY - United States
2023
Immune Regulation of the Synapse Following TBI in Alzheimer’s Models
Jaclyn Iannucci, Ph.D.
College Station, TX - United States
2023
Plasma Biomarkers for Alzheimer’s Disease in Adults in the DRCongo
Jean Ikanga, Ph.D.
Atlanta, GA - United States
2023
Social determinants of health in people with Alzheimer's disease in Peru
Maryenela Illanes-Manrique, M.D.
Lima, Peru
2023
ADRD risk factors in Middle Eastern and North African immigrants in the US
Neda Jahanshad, Ph.D.
Marina del Rey, CA - United States
2023
Digital Storytelling of dementia for healthcare students
Alison Jane Canty, Ph.D.
Tasmania, Australia
2023
Vascular Risk, blood biomarker, and Brain Health in a Tri-Ethnic Population
Xiaqing Jiang,Ph.D.
San Francisco, CA - United States
2023
The Role of Diet in Dementia Prevention
Emily Johnston, M.P.H., Ph.D.
New York, NY - United States
2023
Delirium and dementia diagnosis in hospitalized older adults
Thiago Junqueira Avelino da Silva, Ph.D.
São Paulo, Brazil
2023
Benefits and Burdens of Anticoagulation for Patients with AF and AD/ADRD
Kapoor Alok, M.D.
Worcester, MA - United States
2023
Pilot Study “Drug screen targeting the pathological interaction between LSD1 and tau”
David Katz
Atlanta, GA - United States
2023
Central auditory deficits in the pathogenesis of Alzheimer's disease
Jun Hee Kim, Ph.D.
Ann Arbor , MI - United States
2023
The therapeutic effect of plasma exchange in Amyloid beta (Aß) pathology.
Suélyn Koerich, Ph.D.
Houston, TX - United States
2023
Neuroproteasomes Underlie Formation of Endogenous Tau/RNA Inclusions
Kalin Konrad-Vicario, Ph.D.
New York City, NY - United States
2023
Phenotyping of AD Based on Selective Vulnerability of Locus Coeruleus
Elouise Koops, Ph.D.
Boston, MA - United States
2023
Understanding Synapse Mechanism Underlying Resilience to Alzheimer Disease
Sunny Kumar, Ph.D.
Charlestown, MA - United States
2023
Defining the Role of Adenylate Kinases in Dementia with Lewy Bodies
Namrata Kumari, Ph.D.
Pittsburgh, PA - United States
2023
Regulation of Enteric Neurons by Nerve-Associated Macrophages
Anuradha Kumari, Ph.D.
Atlanta, GA - United States
2023
Social and behavioral symptoms and interactions with the law
Fiona Kumfor, Ph.D.
Sydney, Australia
2023
Molecular signatures of sex-biased cognitive trajectories in a primate
Agnes Lacreuse, Ph.D.
Amherst, MA - United States
2023
The Role of Prolonged Fasting in the Effects of Calorie Restriction on AD
Dudley Lamming, Ph.D.
Madison, WI - United States
2023
Effects of Care and Caregiver Support on ADRD Risk of LGBTQ+ Older Adults
Nik Lampe, Ph.D.
Nashville, TN - United States
2023
Use of MODEL-AD Mice to Assess Effect of Coronavirus Infection on Pathology
Thomas Lane, Ph.D.
Irvine, CA - United States
2023
Misalignment in Circadian Glymphatic System as Trigger of Neurodegeneration
Cristina Lanni, Ph.D.
Pavia, Italy
2023
Targeting Tau Stress Granules for the Treatment of Tauopathies
Glenn Larsen, Ph.D. and Benjamin Wolozin, M.D., Ph.D.
Cambridge, MA - United States
2023
Dissecting Tau Spreading Using Multi-Omics and Novel Mouse Models of AD
Cristian Lasagna Reeves, Ph.D.
Indianapolis, IN - United States
2023
Tau PET Imaging in Alzheimer disease
Antoine Leuzy, Ph.D.
Malmö, Sweden
2023
FAM222A ad Tau pathology in Alzheimer's disease
Jingjing Liang, Ph.D.
Tucson, AZ - United States
2023
PIAS4 A Novel Regulator of Pathological Tau Accumulation and Clearance
Ana Liberman, Ph.D.
Buenos Aires, Argentina
2023
Pharmacoproteomics to prevent side effects of BACE inhibitors for Alzheimer‘s disease
Stefan Lichtenthaler
Bonn, Germany
2023
Detecting TDP-43 Cryptic Exons Across Cell Types and Brain Regions in AD
Jonathan Ling, Ph.D.
Baltimore, MD - United States
2023
Medicare Data to Identify Drugs that Reduce the Risk of Alzheimer’s Disease
Rachel Litke, M.D., Ph.D.
New York, NY - United States
2023
Optimizing Mealtime Care and Outcome Measures for Residents with ADRD
Wen Liu, Ph.D., RN
Iowa City, IA - United States
2023
Super-Resolution Ultrasound to Measure Vascular Pathology in a LOAD Model
Daniel Llano, M.D., Ph.D.
Urbana, IL - United States
2023
Validating and Culturally Tailoring Caregiver Measures of Dementia Care
Hillary Lum, M.D., Ph.D.
Aurora, CO - United States
2023
Impact of ABCA7 mutations on the microglial endolysosomal function
Renzo Mancuso, Ph.D.
Antwerpen, Belgium
2023
Exploring the Human Microglial Secretome in Alzheimer’s Disease
Renzo Mancuso, Ph.D.
Gent, Belgium
2023
Optimization of Blood Biomarker Use in AD Clinical Trials
Marta Mila Aloma, Ph.D.
San Francisco, CA - United States
2023
Targeting KCC2 for rescuing functional impairments in Alzheimer's disease
Majid Mohajerani, Ph.D.
Lethbridge, Canada
2023
Beliefs about Dementia and the Role of Culture among American Indian Families
Heehyul Moon, Ph.D.
Louisville, KY - United States
2023
The role of AD risk factor BIN1 on tau pathology in diabetes mouse models
Daniel Moreira-Silva, Ph.D.
Tampa, FL - United States
2023
5HT2c treatment of psychological symptoms of dementia
David Morgan, Ph.D.
East Lansing, MI - United States
2023
Diffeomorphic Reconstruction of Amygdala Pathology and AD Molecular Changes
Meaghan Morris, M.D., Ph.D.
Baltimore, MD - United States
2023
The role of sex and stress hormones in the earliest stages of AD
Graciela Muniz-Terrera, Ph.D.
Athens, OH - United States
2023
AD Pathology Across Cognition, Mood, and Behavior: More Than Worried Well?
Catherine Munro, Ph.D.
Boston, MA - United States
2023
Role of Sulfide Pathways and Cannabinoid Type 2 Receptors in Aging and AD
Kevin Murnane, Ph.D.
Shreveport, LA - United States
2023
Using epigenomics to identify Alzheimer’s disease risk in gender dysphoria
Ivan Nalvarte, Ph.D.
Solna, Sweden
2023
Genomic Admixture Effects on Neuropathology and Cognition: APOE and Beyond
Michel Naslavsky, Ph.D.
São Paulo, Brazil
2023
Develop a culturally valid quality of life measure for Vietnam
Kim-Huong Nguyen, Ph.D.
Brisbane, Australia
2023
Mechanism of Mitochondria-Targeted AD Therapeutics in Human Brain Cells
Thi Kim Oanh Nguyen, Ph.D.
Rochester, MN - United States
2023
Cortical dMRI microstructure as an early marker of AD pathology
Talia Nir, Ph.D.
Marina Del Rey, CA - United States
2023
Developing 5-HT7 receptor inverse agonist drugs to tackle tau aggregation
Mauro Niso, Ph.D.
Bari, Italy
2023
Promoting Brain Health through Amazonian Dance
Aline Nogueira Haas, Ph.D.
Porto Alegre, Brazil
2023
Alzheimer’s Disease Augments Cerebral Artery Apoptosis to Oxidative Stress
Charles Norton, Ph.D.
Columbia, MO - United States
2023
Interaction of ovarian hormones and APOE4 in Alzheimer's disease
Sarah Renee Ocanas, Ph.D.
Oklahoma City, OK - United States
2023
A training and implementation study on dementia risk reduction in Nigeria.
Adedoyin Ogunyemi, MPH
Lagos, Nigeria
2023
How does pregnancy with Down syndrome causes maternal Alzheimer disease?
Eitan Okun, Ph.D.
Ramat-Gan, Israel
2023
Molecular Dissection of the Pathoconversion of Tau in Alzheimer’s Disease
Kassandra Ori-McKenney, Ph.D.
Davis, CA - United States
2023
Leveraging Alzheimer’s clinical trials datasets to examine sex differences
Judy Pa, Ph.D.
San Diego , CA - United States
2023
The Mechanisms Driven by Microglial FOXO3 Underlying AD Progression
Jihye Paik, Ph.D.
New York, NY - United States
2023
Targeting Cervical Lymphatics to Identify Biomarkers for Early AD Detection
Yijun Pan, Ph.D.
Parkville, Australia
2023
Therapeutic Poetry Program for Indigenous People Living with Dementia
Antonio Paniagua Guzman, Ph.D.
Duluth, MN - United States
2023
Metabolite Signatures of Mediterranean Diet, Cognitive Change and AD Risk
Christopher Papandreou, Ph.D.
Tarragona, Spain
2023
An iPSC-based toolbox to investigate endolysosomal mechanisms in FTD-GRN
Dominik Paquet, Ph.D.
Munich, Germany
2023
Local synaptic protein biogenesis in tauopathy
Joongkyu Park, Ph.D.
Detroit, MI - United States
2023
Biopsychosocial Predictors of Cognitive Resilience in African Americans
Soohyun Park, Ph.D.
Belmont, MA - United States
2023
Walking the Talk for Dementia Scientific Symposium 2023
Fernando Peres
Vigo, Spain
2023
Effect of glial ApoE on TBI and tau-mediated neurodegeneration
Enmanuel Perez, M.D., Ph.D.
St. Louis, MO - United States
2023
Role of amyloid angiopathy in AD-related perivascular protein accumulation
Valentina Perosa, M.D., Ph.D.
Boston, MA - United States
2023
Modifiable Environmental Exposures in Relation to Brain Health
Marcia Pescador Jimenez, Ph.D.
Boston, MA - United States
2023
Investigating the Mechanism of a Music-based Intervention for Sleep
Diana Petrovsky, Ph.D.
Newark, NJ - United States
2023
Enhancing Retromer Function: A Novel Therapeutic Strategy for Tauopathies
Gregory Petsko, Ph.D.
Boston, MA - United States
2023
Targeting microglial ADGRG/GPR56 to prevent Alzheimer’s disease progression
Xianhua Piao, Ph.D.
San Francisco, CA - United States
2023
Uncovering Immune Mechanisms and Biomarkers of ARIA (UNIMIB-ARIA Toolkit)
Fabrizio Piazza, Ph.D.
Milano, Italy
2023
Organelle contact sites as determinants of endolysosomal activity in AD
Paola Pizzo, Ph.D.
Padova, Italy
2023
Black Caregivers' Daily Experiences and Sleep in Dementia Care Dyads
Courtney Allyn Polenick, Ph.D.
Ann Arbor, MI - United States
2023
Decision-Making Regarding Mechanical Ventilation in Adults with Dementia
Lauren Pollack, M.D.
Seattle, WA - United States
2023
Supporting Needs of Care Partners of Persons with Dementia and Hearing Loss
Danielle Powell, M.D.
Baltimore, MD - United States
2023
Mouse to Human Translation in Alzheimer's Disease
Marco Prado, Ph.D.
London, Canada
2023
Alzheimer's disease pathogenesis in mothers: a role for age and menopause
Alesia Prakapenka, Ph.D.
Downers Grove, IL - United States
2023
Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype in dementia
Le Qi, Ph.D
Los Angeles, CA - United States
2023
Examining vascular risk and menopausal age on women’s increased risk for AD
Jennifer Rabin, Ph.D.
Toronto, Canada
2023
New IDEAS - Transportation Assistance Funding
Gil Rabinovici
San Francisco, CA - United States
2023
Neuroproteasomes modulate endosome trafficking and processing
Kapil Ramachandran, Ph.D.
New York, NY - United States
2023
Role of glypican-4 in APOE4-mediated neurodegeneration
Sivaprakasam Ramamoorthy, Ph.D.
Bangalore, India
2023
Sex, socioeconomical and genetic risk factors in early AD-type pathology
Karen Luiza Ramos Socher, M.D.
São Paulo, Brazil
2023
Using Mobile Technology to Inform Driving Decision-Making in Dementia
Mark Rapoport, M.D.
Toronto, Canada
2023
AD-EpiMark: Exploring the tRNA epitranscriptome as a novel AD modifier
Ana Raquel Soares, Ph.D.
Aveiro, Portugal
2023
Imaging of Astrogliosis and Functional Connectivity in Alzheimer's Disease
Boris-Stephan Rauchmann, M.D.
Munich, Germany
2023
Biased GPR3 signaling mediates glial activation in Alzheimer's Disease.
Roberta Reis, Ph.D.
Pittsburgh, PA - United States
2023
Single cell atlas of human resilience factors against Alzheimer's dementia
Jessica Rexach, M.D., Ph.D.
Los Angeles, CA - United States
2023
Using Computational Linguistics for Early Detection of Alzheimer's Disease
Neguine Rezaii, M.D.
Boston, MA - United States
2023
Role of gamma-delta T cells in modulating the pathogenesis of AD and FTD.
Rafael Rezende, Ph.D.
Boston, MA - United States
2023
Impact of education and occupation on gender differences in dementia
Judith Rijnhart, Ph.D.
Tampa, FL - United States
2023
Self-disclosure about dementia on social media: evidence-informed guidance
Julie Robillard, Ph.D.
Vancouver, Canada
2023
Patient-reported outcome measures for social robots in dementia care
Julie Robillard, Ph.D.
Vancouver, Canada
2023
Cognitive Failure in AD: NPTX2 Dysregulation by ACh- and Aß-Mechanisms
Seung-Eon Roh, Ph.D.
Baltimore, MD - United States
2023
Synergistic contributions of APOE and vascular risk to cognitive decline
Emily Rosenich, Ph.D.
Clayton, Australia
2023
Effect of Statins on APOE Levels, Lipid Metabolism, and Tau Pathology
Michelle Rudman, M.D., Ph.D.
St. Louis, MO - United States
2023
Degrading Pathogenic Tau Conformers Through 20S Proteasome Activation
Bryan Ryder, Ph.D.
San Francisco, CA - United States
2023
AD Risk in Adults With/Without ADHD histories: A study of early biomarkers
Brooke S.G. Molina, Ph.D.
Pittsburgh, PA - United States
2023
Characterizing transcriptional regulators of astrocytes heterogeneity in AD
Ibrahim Saliu, Ph.D.
St. Louis, MO - United States
2023
Synaptic Proteome in Genetic Frontotemporal Lobar Degeneration
Rowan Saloner, Ph.D.
San Francisco, CA - United States
2023
Alzheimer’s Risk Factors and Acculturation in Brazilian Immigrants
Sharon Sanz Simon, Ph.D.
New York, NY - United States
2023
Studying transposable elements abundance in Alzheimer’s disease brains
Muralidharan Sargurupremraj, Ph.D.
San Antonio, TX - United States
2023
Samuel Sathyanesan, Ph.D.
Vermillion, SD - United States
2023
Aß42’s Cell Autonomous Effects on Adult Olfactory Neurogenesis
Ankur Saxena, Ph.D.
Chicago, IL - United States
2023
Late-Stage Development of a PIKFYVE Antisense Oligonucleotide Treatment for FTD
Peter Sazani, Ph.D.
Monrovia, CA - United States
2023
Genomic integrity in Alzheimer's disease
Johannes Schlachetzki, M.D.
La Jolla, CA - United States
2023
AI Assisted Neuropathological Assessment of Sporadic Alzheimer's Cases
Diego Sepulveda-Falla, Ph.D.
Hamburg, Germany
2023
Molecular simulations to investigate protective mutations of APOE proteins
Qing Shao, Ph.D.
Lexington, KY - United States
2023
A BCAA-Lowering Compound as a Novel Approach to Delay the Onset of AD
Andrew Shin, Ph.D.
Lubbock, TX - United States
2023
Music Stimulation for Physical Activity of Older Adults at Risk of Dementia
Kyoung Shin Park, Ph.D.
Greensboro, NC - United States
2023
Challenges in health seeking behavior among hypertensive adults in Nepal
Prabha Shrestha
Dhulikhel, Nepal
2023
Obesity-related vascular impairment contributes to Alzheimer’s disease
Catrina Sims Robinson, Ph.D.
Charleston, SC - United States
2023
Neureka Latin America: A scalable digital tool to assess brain health
Maria Sol Fittipaldi, Ph.D.
Santiago, Chile
2023
The link between axon damage in traumatic brain injury and tau pathogenesis
Hailong Song, Ph.D.
Philadelphia, PA - United States
2023
Longitudinal prefrontal imaging of Aß accumulation and attention coding
Timothy Spellman, Ph.D.
Farmington, CT - United States
2023
Exploring the priorities of people with dementia and multiple comorbidities
Lucy Stirland, Ph.D.
Edinburgh, United Kingdom
2023
Affective Mechanisms of the Decline in Physical Activity in Preclinical AD
Marta Stojanovic, Ph.D.
St. Louis, MO - United States
2023
The Role of Sulfation for cellular Tau pathology in vivo
Barbara Stopschinski, M.D.
Dallas, TX - United States
2023
Crosstalk of Meningeal Lymphatics and the blood-brain barrier
Steffen Storck, Ph.D.
St. Louis, MO - United States
2023
Implementing a Web-based Assessment of Online Money Management
Preeti Sunderaraman, Ph.D.
Boston, MA - United States
2023
Sex hormones in CSF: Neuroendocrine contributions to Alzheimer’s disease
Erin Sundermann, Ph.D.
San Diego, CA - United States
2023
Elucidating the Role of APOE Status on Neurovascular Coupling in ADRD
Paul Territo, Ph.D.
Bloomington, IN - United States
2023
Integration of Clinical Trial MRI data to Neuroimaging Big Data Analytics
Sindhuja Tirumalai Govindarajan, Ph.D.
Philadelphia, PA - United States
2023
Mitochondrial Protein Quality Control and Ca2+ Flux in Alzheimer's Disease
Dhanendra Tomar, Ph.D.
Winston-Salem, NC - United States
2023
Chemotherapy as a risk factor for dementia: the role of senescence and APOE
Matthew Torre, M.D.
Boston, MA - United States
2023
Identifying Culprits of Capillary Stasis in Hypertensive ApoE4 Mice
Lianne Trigiani, Ph.D.
Ithaca, NY - United States
2023
Digital cognitive markers in the preclinical stages of genetic Alzheimer's
Natalia Trujillo, Ph.D.
Medellin, CA - Colombia
2023
Excitability Imbalance in Preclinical Alzheimer's Disease
Nien-Pei Tsai, Ph.D.
Urbana, IL - United States
2023
FemBER-AFRICA: Female Brain Health and Endocrine Research in Africans
Chinedu Theresa Udeh-Momoh, Ph.D.
Nairobi, Kenya
2023
Evaluating impact of a pragmatic preference congruent care measure
Kimberly S Van Haitsma, Ph.D.
University Park, PA - United States
2023
Apolipoprotein Receptor 2 in AD-Related Brain Vessel Dysfunction
Milène Vandal, Ph.D.
Calgary, Canada
2023
Tau Pathology in the Amygdala: Studying Neuropsychiatric Symptoms in AD
Jonathan Vogelgsang, Ph.D.
Belmont, MA - United States
2023
Presenilin2 in Endolysosomal Homeostasis: A Focus on Membrane Contact Sites
Céline Vrancx, Ph.D.
Leuven, Belgium
2023
Impact of APOE on Cerebrovascular Aging
Ashley Walker, Ph.D.
Eugene, OR - United States
2023
Environmental Influences on Circadian Rhythms in Sundowning and Alzheimer's
James Walton, Ph.D.
Morgantown, WV - United States
2023
What is the Role of Axonal Degeneration in Ischemia-Triggered Dementia?
Jack Wang, M.D., Ph.D.
Stanford, CA - United States
2023
Mitophagy and amyloid pathology in Alzheimer's disease
Heather Wilkins, Ph.D.
Kansas City, KS - United States
2023
The Role of Gender-Based Violence in Later-Life Cognitive Disparities
Douglas William Hanes, Ph.D.
Stony Brook, NY - United States
2023
Developing a digital signature of care-related activities and burden.
Neil William Douglas Thomas, M.D.
Ottawa, Canada
2023
Jeff Williamson
Winston-Salem, NC - United States
2023
Mitochondrial optogenetic approaches to modulate tau pathology in vivo
Andrew Wojtovich, Ph.D.
Rochester, NY - United States
2023
Advancing Provider Profiling for Equitable Care in Alzheimer's and Dementia
Wenbo Wu, Ph.D.
New York, NY - United States
2023
The longitudinal relationship between tinnitus and cognitive decline
Anusha Yasoda-Mohan, Ph.D.
Dublin, Ireland
2023
Exploring the SORL1-retromer axis as a novel therapeutic pathway in AD
Jessica Young, Ph.D.
Seattle, WA - United States
2023
Neuronal Circuits Underlying Apathy in Alzheimer's Disease
Guang-Wei Zhang, Ph.D.
Los Angeles, CA - United States
2023
Understanding the Vascular Dysfunctions in MODEL-AD Mouse Models
Zhen Zhao, Ph.D.
Los Angeles, CA - United States
2023
Alzheimer’s disease and a prospective hearing-related serum biomarker
Jing Zheng, Ph.D.
Chicago, IL - United States
2023
Molecular mechanisms and effects of Alzheimer’s-related lipid dysregulation
Till Zimmer, Ph.D.
New York, NY - United States
2023
Interactions of sex hormone receptors and stress in AD
Damian Zuloaga, Ph.D.
Albany, NY - United States
2023
Cerebrovascular endothelial cilia in Alzheimer's Disease and hypertension
Wissam AbouAlaiwi, Ph.D.
Toledo, OH - United States
2022
APP-dependent changes in vesicle refilling following Aß and tau elevation
Erica Acquarone, Ph.D.
New York, NY - United States
2022
Endothelial SOCS3 role in post-shock brain damage and cognitive impairment
Alejandro Adam, Ph.D.
Albany, NY - United States
2022
The role of community-level policing on the health for Black older adults
Paris Adkins-Jackson, Ph.D., MPH
New York, NY - United States
2022
Outcomes and quality of life for people with dementia facing surgery
Rachel Adler, Sc.D.
Boston, MA - United States
2022
Co-Therapy of Nilotinib and Lithium for Treating Alzheimer’s disease
Aida Adlimoghaddam, Ph.D.
Winnipeg, Canada
2022
Association Between Biomarkers of Chronic Stress and Cognition in Latinos
Paula Aduen, Ph.D.
Boston, MA - United States
2022
Microglia Regulation of Alzheimer’s Disease Pathology and Progression
Bahareh Ajami, Ph.D.
Portland, OR - United States
2022
The Bloom Social Therapeutic Horticultural,Healing-Garden Project for Elderly
Funmi Akindejoye
Ibadan, Nigeria
2022
Role of child gut microbiota on adult Alzheimer's disease susceptibility
Ziad Al Nabhani, Ph.D.
Bern, Switzerland
2022
Early microglia–neuron interactions in Alzheimer's Disease
Giulia Albertini, Ph.D.
Gent, Belgium
2022
Characterizing Neurocognitive and Social Health in Ecuador
Kuripacha Alcamari Tituana Vega, M.D.
Quito, Ecuador
2022
A New Prospect in Triggering Early Hyperexcitability in Alzheimer’s Disease
David Alcantara-Gonzalez, Ph.D.
Menands, NY - United States
2022
CGRP Pathways in Clinicopathogically -established Parkinson Disease
Athanasia Alexoudi, Ph.D.
Athens, Greece
2022
Engineered Decoy Viral Inhibitors (DEVi) to Prevent Tau Spread by LRP1
Gaya Amarasinghe, Ph.D.
St. Louis, MO - United States
2022
Health Outcomes of Transitional Space Design for Older Adults with Dementia
Diana Anderson, M.D., M. Arch
Boston, MA - United States
2022
Ancestry-specific effects of APOE on AD endophenotypes and risk factors
Shea J. Andrews, Ph.D.
New York, NY - United States
2022
Selective mTOR Inhibition to Treat Alzheimer's Disease
Zoltan Arany, M.D., Ph.D.
Philadelphia, PA - United States
2022
Role of Social Interaction and Physical Activity in Brain Health in FTD
Faheem Arshad, D.M.
Bengaluru, India
2022
Microglia Structure and Function in Tau Pathology and During Treatment
Alejandro Avila, Ph.D.
New York, NY - United States
2022
Influence of Structural Sexism and Racism on AD Risk
Justina Avila-Rieger, Ph.D.
New York, NY - United States
2022
Cellular events that shape microglial identity in Alzheimer's disease
Pinar Ayata, Ph.D.
New York, NY - United States
2022
Early Identification of Neurodegenerative Dementias in Psychiatry Clinics
Yavuz Ayhan, M.D.
Ankara, Turkey
2022
Aging Research Characterizing Health Equity via Social determinants (ARCHES)
Ganesh Muneshwar Babulal
St. Louis, MO - United States
2022
Impact of White Adipose Tissue on Tau Pathology in Transgenic Mice
David Baglietto-Vargas, Ph.D.
Málaga, Spain
2022
Electrophysiological Measures of pProteinopathy in Asymptomatic Older Adults
Sylvain Baillet, Ph.D.
Montreal, Canada
2022
The role of epilepsy in Tau propagation in Alzheimer's Disease
Aaron Barbour, Ph.D.
Philadelphia, PA - United States
2022
Metabolic Trajectories of Alzheimer’s Disease Progression
Richa Batra, Ph.D.
Ithica, NY - United States
2022
APP4PPA: A Remote Speech-Language Therapy for Italian PPA
Petronilla Battista, Ph.D.
Pavia, Italy
2022
Multimodal Imaging of Small Vessel Disease in Genetic AD
Alexandre Bejanin, Ph.D.
Barcelona, Spain
2022
Role of synaptic miRNA and astrocyte miRNA delivery in Alzheimer’s disease
Olivia Belbin, Ph.D.
Barcelona, Spain
2022
Glial signatures of tau propagation in Alzheimer's disease
Bruna Bellaver, Ph.D.
Pittsburgh, PA - United States
2022
Assessing Technology Use in Activities of Daily Living
Jared Benge, Ph.D.
Austin, TX - United States
2022
Social connection in long-term care home residents
Jennifer Bethell, Ph.D.
Toronto, Canada
2022
Neuroregeneration in Alzheimer’s Disease
Sanjoy Bhattacharya, Ph.D.
Coral Gables, FL - United States
2022
Strategies Disrupting the Feed-Forward Mechanism of Aß Production.
Elena Anahi Bignante, Ph.D.
Cordoba, Argentina
2022
Tau and ApoE coalescence, the bridge to impaired brain lipid homeostasis
Melissa Birol, Ph.D.
Berlin, Germany
2022
Role of Rho GTPases during amyloid-ß induced neuronal degeneration
Mariano Bisbal, Ph.D>
Cordoba, Argentina
2022
Developing risk and resiliency models of neuropsychiatric symptoms in AD
Laura Blair, Ph.D.
Tampa, FL - United States
2022
Disclosing Dementia Risk Based on Plasma Phosphorylated Tau: A Pilot Study
Corey Bolton, Psy.D.
Nashville, TN - United States
2022
An Emergency Plan Toolkit to Change Outcomes for Caregivers and Persons Living with Dementia
Rebecca Boxer, M.D.
Aurora, CO - United States
2022
Single-cell analysis of neutrophil subpopulations Alzheimer’s disease mice
Oliver Bracko, Ph.D.
Coral Gables, FL - United States
2022
Investigating the Protective Mechanisms of APOE2
David Adam Brafman, Ph.D.
Tempe, AZ - United States
2022
Neutrophil Extracellular Traps in Amyloid Pathology & Glymphatic Impairment
Molly Braun, Ph.D.
Seattle, WA - United States
2022
Linking Vascular Cognitive Impairment and Alzheimer Disease Risk in Midlife
Adam Brickman, Ph.D.
New York, NY - United States
2022
Novel Alzheimer’s disease transethnic polygenic risk scores in Latinos
Iris Broce-Diaz, Ph.D.
San Diego , CA - United States
2022
Role of MAIT cells and MR1 in AD Development
Randy Brutkiewicz, Ph.D.
Bloomington, IN - United States
2022
Untangling the Link Between Insulin Resistance and AD through Metabolomics
Mònica Bulló, Ph.D.
Tarragona, Spain
2022
Glial cell-surface proteomics for brain aging and Alzheimer’s Disease
Madeline Burns, Ph.D.
Houston, TX - United States
2022
From Space to Memory Under Pathological Tau
James Carmichael, Ph.D.
Montreal, Canada
2022
Multimodal Assessment of Brain Inflammatory Biomarkers in DS-associated AD
Maria Carmona Iragui, MD, Ph.D.
Barcelona, Spain
2022
Amplifying the voices of people with dementia and carers in South Africa
Melissa Chan
Lamontville, South Africa
2022
Visual Attention and Postoperative Delirium
Benjamin Chapin, M.D.
Gainesville, FL - United States
2022
Modulate neuroinflammation by targeting microglia with CSF1Ri EI1071
Hung-Kai Chen, M.D., Ph.D.
Taipei, Taiwan
2022
Mapping and modeling interneuron dysfunction in Alzheimer’s Disease
Kevin Chen, M.D.
Ann Arbor, MI - United States
2022
The chaperone domain BRICHOS in prevention/treatment of Alzheimer's disease
Gefei Chen, Ph.D.
Solna, Sweden
2022
A Drug Screening Assay to Reduce LINGO-1 Amounts in Neurons
Brian Chen, Ph.D.
Montreal, Canada
2022
E-Tailored Pain Management Support for Dementia Family Caregivers
Nai-Ching Chi, Ph.D.
Iowa City, IA - United States
2022
Sex-Dependent Genetic Landscape of Late-Onset Alzheimer's Disease
Ornit Chiba-Falek, Ph.D.
Durham, NC - United States
2022
Revealing Combinations of Haplotypes Associated with Alzheimer Disease
Sharlee Climer, Ph.D.
St. Louis, MO - United States
2022
Engineered Tau Immunotherapies for Alzheimer's disease
Todd Cohen, Ph.D.
Chapel Hill, NC - United States
2022
Marcia Cominetti, Ph.D.
Sao Carlos, Brazil
2022
Mechanisms of SORLA Mediated Tau Uptake and Seeding
Joanna Cooper, Ph.D.
Baltimore, MD - United States
2022
Advancing Person-Centered Dementia Care in Low-Resource Contexts
Kirsten Corazzini, Ph.D.
Baltimore, MD - United States
2022
Probing the role of PTK2B-STAT3 signaling on neuronal vulnerability in AD
Marcos Costa, Ph.D.
Lille, France
2022
A Phase IIA Trial of Empagliflozin and Intranasal Insulin for MCI/AD
Suzanne Craft, Ph.D.
Winston-Salem, NC - United States
2022
Backbone DegradablePolymer-drug Conjugate for Treatment of AD
Donna Cross, Ph.D.
Salt Lake City, UT - United States
2022
Detailed Proteomic Landscape of Alzheimer Disease
Carlos Cruchaga, Ph.D.
St. Louis, MO - United States
2022
Propagation of Mitochondrial Dysfunction in the Brain by Mitovesicles
Pasquale D'Acunzo, Ph.D.
Menands, NY - United States
2022